Description

Ederimotide(WT-1 A1) can be used as a potential target for studying pancreatic cancer[1].—–C55H74N10O13S—-[1]WHO Drug Information. International Nonproprietary Names for Pharmaceutical.–852243-39-1–1115.30—-O=C(N(CCC1)[C@@H]1C(N[C@@H](CC(N)=O)C(N[C@@H](C)C(N(CCC2)[C@@H]2C(N[C@H](C(N[C@H](C(O)=O)CC(C)C)=O)CC(C=C3)=CC=C3O)=O)=O)=O)=O)[C@@H](NC([C@H](CCSC)NC([C@@H](N)CC(C=C4)=CC=C4O)=O)=O)CC5=CC=CC=C5–Cancer–10 mM in DMSO–Others—-Others–Peptides